In Dubai, "pool season" is something of a misnomer. The city's rooftop pools and JBR beach clubs never really close — but the social intensity peaks again in late autumn. The researchers who understand tesamorelin know this: the peptide's VAT reduction effects at 2 mg/day over 26 weeks (Falutz 2010) take months to accumulate. If you want to observe an outcome by September or October, you initiate the protocol now, in late June, and you do it with cold-chain-verified, HPLC-tested vials from a UAE supplier who actually stocks them. That is what this guide is for — and it is also why REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates, available same-day in Dubai or 24h anywhere in the UAE.
Tesamorelin is a synthetic analog of endogenous human growth-hormone-releasing hormone (GHRH 1-44), with a trans-3-hexenoic acid group added to the N-terminus. That structural tweak does two things at once: it confers resistance to cleavage by dipeptidyl peptidase-IV (DPP-IV), dramatically extending the molecule's half-life compared to native GHRH, and it preserves the original peptide's ability to bind and activate GHRH receptors on pituitary somatotrophs. The downstream result is an amplification of natural pulsatile GH secretion — not a flat supraphysiological GH spike, but a restoration of the normal GH pulse pattern that blunts with age, metabolic stress, and visceral fat accumulation itself.
This mechanism is precisely what separates tesamorelin from blunter tools. It does not suppress the hypothalamic-pituitary axis; it works through it. And the effect is selective: the robust clinical evidence is specifically for visceral adipose tissue, not subcutaneous fat. For a researcher in Dubai whose investigative question involves the relationship between trunk body composition and metabolic markers, that selectivity matters.
The chain from peptide injection to measurable VAT effect is well-mapped. It is also slow: the Falutz 2007 NEJM trial ran 26 weeks, and the 2010 extension ran another 26 weeks. Investigators who initiate in late June in Dubai are timing correctly for a meaningful autumn observation window.
Four landmark trials define the tesamorelin evidence base — and only these four should anchor any research-context write-up. Here is what each found:
| Study | Journal | Design | Key Outcome |
|---|---|---|---|
| Falutz et al. 2007 | N Engl J Med | 26-week RCT, 412 subjects, 2 mg/day SC | VAT −15 to −18% vs placebo; IGF-1 +~50% |
| Falutz et al. 2010 | J Clin Endocrinol Metab | 26-week extension of 2007 trial | Sustained VAT reduction; visceral and liver fat maintained |
| Stanley et al. 2014 | JAMA | RCT, HIV-associated NAFLD, 26 weeks | Liver fat −32% vs placebo; VAT reduction confirmed |
| Stanley et al. 2019 | Lancet HIV | 12-month NAFLD extension, double-blind | Hepatic fat reduction durable at 12 months; cardiometabolic markers improved |
A note on generalizability that responsible investigators keep in mind: all four trials were conducted in patients with specific metabolic pathology (lipodystrophy, HIV-associated NAFLD). Extrapolating to healthy-subject research requires careful framing. The mechanism is the same; the magnitude of effect in a metabolically average subject is an open investigative question. What the data does establish unambiguously is the molecule's safety profile, its pharmacodynamic signature (GH pulse amplification, IGF-1 rise, VAT reduction), and its dose range — 1 mg to 2 mg per day subcutaneously, which is the only research-context dosing window cited across all four trials.
The trials that defined tesamorelin's effect profile used a 26-week observation window at 2 mg/day. That is the anchor. A 12-week observation at 1 mg/day is a common shorter-window design referenced in derivative literature, with proportionally smaller but still directionally consistent results. Here is how investigators in Dubai typically structure a summer cycle:
| Protocol Window | Daily Dose (Research Context) | Vials Needed | REVIVE LAB Vial Option |
|---|---|---|---|
| 12 weeks (84 days) | 1 mg/day | ~9 × 10 mg (or 17 × 5 mg) | 10 mg preferred for economy |
| 12 weeks (84 days) | 2 mg/day | ~17 × 10 mg (or 34 × 5 mg) | 10 mg strongly preferred |
| 26 weeks (182 days) | 1 mg/day | ~19 × 10 mg (or 37 × 5 mg) | 10 mg preferred for economy |
| 26 weeks (182 days) | 2 mg/day | ~37 × 10 mg (or 73 × 5 mg) | 10 mg — batch order recommended |
Stocked strengths: REVIVE LAB UAE carries tesamorelin in 5 mg and 10 mg vials only. These are the two concentrations available — do not expect 1 mg or 2 mg pre-filled vials. Investigators draw and dose from the standard vials using an insulin syringe; the math is covered in the reconstitution section below.
A 26-week cycle initiated on 28 June 2026 concludes in late December — well after autumn social events and the November-to-February Dubai peak season. A 12-week cycle ends in late September. Both are rational calendar targets for a UAE-based investigator. The practical consideration is not the calendar but the cold chain: Dubai's July-August ambient temperatures routinely exceed 45°C, which makes every storage and delivery decision consequential.
This is where UAE-specific research discipline matters most. Lyophilized tesamorelin is stable at 2-8°C for the vial's shelf life and tolerates brief ambient excursions (under 30°C) of up to approximately 7 days without significant degradation. Once reconstituted, the peptide is in solution and the stability window drops to roughly 7-14 days at 2-8°C. In a Dubai summer where your car park hits 55°C and the gap between your fridge and your front door represents a real thermal risk, every step in the chain deserves a protocol.
| Storage Stage | Target Temp | UAE Summer Consideration |
|---|---|---|
| Lyophilized in fridge | 2-8°C | Dedicated shelf, not door (door fluctuates) |
| Lyophilized transit (delivery) | 2-10°C | REVIVE LAB UAE cold-chain insulation handles this |
| Post-reconstitution in fridge | 2-8°C | Verify with fridge thermometer — UAE summer compressors can struggle |
| Drawing the dose | Ambient (brief) | Remove vial, draw dose immediately, return vial — do not let sit on bench |
| Vials at beach / pool | Not applicable | Never transport reconstituted vials outside controlled cold storage |
If you are staying in a hotel in Dubai Marina, Palm Jumeirah, DIFC, or Downtown during a cycle, the hotel mini-bar is not a research fridge. Testing across Dubai properties consistently shows mini-bars running at 8-14°C — well above the 2-8°C spec. The practical solutions: request a dedicated medical fridge from the hotel (most five-star properties have them), use a USB-powered Peltier cooler, or — the cleanest answer — order fresh vials from REVIVE LAB UAE on arrival rather than transporting reconstituted product from home.
Both the Falutz and Stanley trials used subcutaneous injection as the route of administration for all tesamorelin doses. Reconstitution is done with bacteriostatic water (BAC water). Inject BAC water slowly down the side of the vial — never directly onto the lyophilized cake — and swirl gently. Never shake. Here is the standard concentration math for REVIVE LAB UAE vials:
| Vial | BAC Water Added | Final Concentration | Volume per 1 mg dose | Volume per 2 mg dose |
|---|---|---|---|---|
| Tesamorelin 5 mg | 1 mL | 5 mg/mL | 0.20 mL (20 IU) | 0.40 mL (40 IU) |
| Tesamorelin 5 mg | 2 mL | 2.5 mg/mL | 0.40 mL (40 IU) | 0.80 mL (80 IU) |
| Tesamorelin 10 mg | 2 mL | 5 mg/mL | 0.20 mL (20 IU) | 0.40 mL (40 IU) |
| Tesamorelin 10 mg | 4 mL | 2.5 mg/mL | 0.40 mL (40 IU) | 0.80 mL (80 IU) |
Investigators typically choose the 5 mg/mL concentration to minimize injection volume. A 10 mg vial reconstituted to 2 mL at 5 mg/mL gives exactly 5 doses at 1 mg each, or 5 days at 2 mg — making cycle math clean and reducing the risk of partial-vial waste in UAE summer heat. Use each reconstituted vial within 7 days if possible; do not push to 14 days in summer conditions where fridge reliability is uncertain.
REVIVE LAB UAE is a Dubai-based peptides UAE supplier with HPLC-verified, lot-COA tesamorelin in stock right now. Every batch is tested to ≥99% purity. Vials are cold-chain dispatched in validated insulation that holds 2-8°C through any UAE summer transit — which matters more in June than it does in January. Payment options include cash on delivery Dubai, and USDT crypto pay Dubai via Binance Pay (TRC20) for a 5% pre-pay discount.
| Emirate / Zone | Delivery Window | Cash on Delivery | Cold-Chain |
|---|---|---|---|
| Dubai (Marina, JBR, Palm, DIFC, Downtown, Business Bay, JVC, Jumeirah) | Same-day, 4-8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem) | Next-day, 18-24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Ajman | Next-day, 18-24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18-24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18-24 hours | Yes | Yes |
| Al Ain | Next-day, 24 hours | Yes | Yes |
For investigators in Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, or Downtown, ordering before 2pm typically means cold vials are in hand the same evening. This makes batch planning straightforward: order a week's supply at a time, keep reconstituted vials at 2-8°C, and reorder via REVIVE LAB UAE before the previous batch runs out — no need to stockpile weeks of vials and manage extended cold storage in UAE summer.
REVIVE LAB UAE stocks tesamorelin in 5 mg and 10 mg HPLC-verified vials, cold-chain dispatched across all 7 emirates. Investigators running a summer pool cycle research protocol typically reference 1 mg or 2 mg per day dosing windows drawn from the Falutz et al. 2007 NEJM trial and Stanley et al. 2014 JAMA trial. The 10 mg vial offers better economy for multi-week protocols; the 5 mg vial suits shorter observation windows or lower dosing schedules. No other strengths are stocked — 1 mg pre-filled vials are not available and should not be sought from any supplier claiming to stock them.
Lyophilized tesamorelin vials must be kept at 2-8°C at all times — in a verified, calibrated fridge, never a hotel mini-bar which typically runs 8-14°C. Once reconstituted, the stability window is approximately 7-14 days at 2-8°C, but investigators should target 7 days in UAE summer conditions to account for fridge variability. The practical answer for Dubai summer cycles is to order in smaller, more frequent batches via tesamorelin same day Dubai delivery from REVIVE LAB UAE, rather than stockpiling and risking heat excursions. REVIVE LAB UAE dispatches with validated cold-chain insulation that holds 2-8°C through any UAE summer transit.
Yes. REVIVE LAB UAE offers tesamorelin same day Dubai delivery for orders placed before the daily cut-off, and tesamorelin 24h delivery across all seven emirates. Payment options include cash on delivery Dubai across all UAE emirates, and USDT crypto pay Dubai via Binance Pay (TRC20) with a 5% pre-pay discount applied at checkout — confirmed via WhatsApp transaction ID. All shipments are cold-chain dispatched in plain, unbranded outer packaging as standard. REVIVE LAB UAE ships tesamorelin in stock UAE — not a pre-order, not drop-shipped from overseas.